AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33414139 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 232
Study 33414139 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture
Number of subjects: 232
Study 33414139 — intervention group
Group type: COMPARATOR
Intervention: Waiting-list group
Number of subjects: 232
Study 32286620 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 egg per day for 6 months
Number of subjects: 660
Study 32286620 — intervention group
Group type: COMPARATOR
Intervention: Control group (no eggs provided)
Number of subjects: 660
Study 35394723 — intervention group
Group type: EXPERIMENTAL
Intervention: Alental cream
Number of subjects: 131
Study 35394723 — intervention group
Group type: COMPARATOR
Intervention: Aertal cream
Number of subjects: 131
Study 34458708 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled RT-qPCR testing using oropharyngeal swabs or buccal swabs
Number of subjects: 3970
Study 34458708 — intervention group
Group type: EXPERIMENTAL
Intervention: Pooled saliva swabs using the 'lolli method'
Number of subjects: 3970
Study 34458708 — intervention group
Group type: COMPARATOR
Intervention: Cumulative incidence in primary schools
Number of subjects: 3970
Study 34458708 — intervention group
Group type: COMPARATOR
Intervention: Cumulative incidence in secondary schools
Number of subjects: 3970
Study 32972259 — intervention group
Group type: EXPERIMENTAL
Intervention: Aversive video
Number of subjects: 562
Study 32972259 — intervention group
Group type: COMPARATOR
Intervention: Control video
Number of subjects: 562
Study 35501931 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-aminopyridine (4-AP) treatment initiated one day post-injury
Number of subjects: 2
Study 35501931 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-aminopyridine (4-AP) treatment
Number of subjects: 2
Study 32014842 — intervention group
Group type: EXPERIMENTAL
Intervention: PATHway (PW) intervention group
Number of subjects: 120
Study 32014842 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) control group
Number of subjects: 120
Study 34318563 — intervention group
Group type: EXPERIMENTAL
Intervention: RNA interference-mediated knockdown of lnc94638 expression
Number of subjects: 0
Study 34318563 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 35272249 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry-needling together with exercise therapy (DNG)
Number of subjects: 70
Study 35272249 — intervention group
Group type: COMPARATOR
Intervention: Exercise-only group (EG)
Number of subjects: 70
Study 33222767 — intervention group
Group type: EXPERIMENTAL
Intervention: MD1003 (oral biotin 100 mg three times daily)
Number of subjects: 642
Study 33222767 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 642
Study 33222767 — intervention group
Group type: EXPERIMENTAL
Intervention: MD1003
Number of subjects: 642
Study 34989016 — intervention group
Group type: EXPERIMENTAL
Intervention: Intense Pulsed Light (IPL) treatment
Number of subjects: 17
Study 34989016 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated side)
Number of subjects: 17
Study 34592639 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg ketamine infusion
Number of subjects: 71
Study 34592639 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg ketamine infusion
Number of subjects: 71
Study 34592639 — intervention group
Group type: COMPARATOR
Intervention: Normal saline placebo
Number of subjects: 71
Study 34592639 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose ketamine infusion
Number of subjects: 71
Study 35252455 — intervention group
Group type: EXPERIMENTAL
Intervention: Acutreatment (n=30)
Number of subjects: 57
Study 35252455 — intervention group
Group type: COMPARATOR
Intervention: Sham Acutreatment (placebo, n=27)
Number of subjects: 57
Study 33781394 — intervention group
Group type: EXPERIMENTAL
Intervention: Illness Management and Recovery Program (10 modules, 20 sessions)
Number of subjects: 50
Study 33781394 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face interview (Control)
Number of subjects: 50
Study 33781394 — intervention group
Group type: EXPERIMENTAL
Intervention: Illness Management and Recovery Program
Number of subjects: 50
Study 33161105 — intervention group
Group type: EXPERIMENTAL
Intervention: Probucol combined with mecobalamin tablets
Number of subjects: 104
Study 33161105 — intervention group
Group type: COMPARATOR
Intervention: Control (mecobalamin tablets only)
Number of subjects: 104
Study 35468729 — intervention group
Group type: EXPERIMENTAL
Intervention: Ubrogepant 50 mg
Number of subjects: 1799
Study 35468729 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1799
Study 32779029 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Reality (VR)
Number of subjects: 66
Study 32779029 — intervention group
Group type: COMPARATOR
Intervention: Standard of care (videos, television, iPad, child life specialist)
Number of subjects: 66
Study 33631604 — intervention group
Group type: EXPERIMENTAL
Intervention: PFAS exposure (specifically PFOS and N-ethyl-perfluorooctane sulfonamido acetic acid)
Number of subjects: 666
Study 33631604 — intervention group
Group type: EXPERIMENTAL
Intervention: PFOS (linear isomer)
Number of subjects: 666
Study 33631604 — intervention group
Group type: EXPERIMENTAL
Intervention: N-ethyl-perfluorooctane sulfonamido acetic acid
Number of subjects: 666
Study 33631604 — intervention group
Group type: EXPERIMENTAL
Intervention: PFOS and n-PFOS
Number of subjects: 666
Study 32432550 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based music intervention (supervised sessions 3 times during stay)
Number of subjects: 81
Study 32432550 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-based music intervention (unsupervised use by participant)
Number of subjects: 81
Study 32432550 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall feedback from participants
Number of subjects: 81
Study 35484429 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin infusion at 10 IU/h
Number of subjects: 105
Study 35484429 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin infusion at 5 IU/h
Number of subjects: 105
Study 35484429 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin infusion at 2.5 IU/h
Number of subjects: 105
Study 34750127 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinicians perceived organizational cultures with an emphasis on quality
Number of subjects: 165
Study 34750127 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinicians perceived organizational cultures with an emphasis on communication and information
Number of subjects: 165
Study 34750127 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinicians perceived organizational cultures with cohesiveness among clinicians
Number of subjects: 165
Study 34750127 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinicians perceived organizational cultures with values alignment between clinicians and leaders
Number of subjects: 165
Study 34616527 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel treatment
Number of subjects: 88
Study 34616527 — intervention group
Group type: COMPARATOR
Intervention: Conventional acute angina pectoris drugs
Number of subjects: 88
Study 33863746 — intervention group
Group type: EXPERIMENTAL
Intervention: Nocturnal oxygen (n=13)
Number of subjects: 23
Study 33863746 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP treatment (n=17)
Number of subjects: 23
Study 33863746 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=13)
Number of subjects: 23
Study 33863746 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent hypoxia (IH) (n=8)
Number of subjects: 23
Study 33863746 — intervention group
Group type: COMPARATOR
Intervention: Normoxia (n=7)
Number of subjects: 23
Study 32894251 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote video-based visits
Number of subjects: 40
Study 34588252 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron (50 mg orally once a day)
Number of subjects: 120
Study 34588252 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 35393934 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief behavioral treatment for insomnia (BBTI, 4 sessions)
Number of subjects: 91
Study 35393934 — intervention group
Group type: COMPARATOR
Intervention: Progressive muscle relaxation therapy (active control)
Number of subjects: 91
Study 35360485 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese medicine hot ironing technique intervention
Number of subjects: 92
Study 35360485 — intervention group
Group type: COMPARATOR
Intervention: Sodium hyaluronate eye drops
Number of subjects: 92
Study 37244291 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily multivitamin supplement (Centrum Silver)
Number of subjects: 3562
Study 37244291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3562
Study 33317349 — intervention group
Group type: EXPERIMENTAL
Intervention: 505 change of direction (CoD) test
Number of subjects: 39
Study 33317349 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-m sprint test
Number of subjects: 39
Study 33317349 — intervention group
Group type: EXPERIMENTAL
Intervention: change of direction deficit test (CoDD)
Number of subjects: 39
Study 32234999 — intervention group
Group type: COMPARATOR
Intervention: Sand surface during Single-Leg Landing (SLL) tasks
Number of subjects: 31
Study 32234999 — intervention group
Group type: EXPERIMENTAL
Intervention: Land surface during Single-Leg Landing (SLL) tasks
Number of subjects: 31
Study 32234999 — intervention group
Group type: COMPARATOR
Intervention: Sand surface during Drop Jump (DJ) tasks
Number of subjects: 31
Study 32234999 — intervention group
Group type: EXPERIMENTAL
Intervention: Land surface during Drop Jump (DJ) tasks
Number of subjects: 31
Study 32234999 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of SLL tasks between males and females
Number of subjects: 31
Study 35787963 — intervention group
Group type: COMPARATOR
Intervention: Corticosteroid Randomization after Significant Head Injury (CRASH) model
Number of subjects: 423
Study 34797353 — intervention group
Group type: EXPERIMENTAL
Intervention: CD3+ tumor-infiltrating lymphocytes (TIL)
Number of subjects: 83
Study 33992767 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer Navigation Social Support for smoking cessation (PNSS-S)
Number of subjects: 72
Study 33992767 — intervention group
Group type: COMPARATOR
Intervention: Standard cessation counseling
Number of subjects: 72
Study 35654566 — intervention group
Group type: EXPERIMENTAL
Intervention: Brush/Floss/Rinse (BFR)
Number of subjects: 213
Study 35654566 — intervention group
Group type: EXPERIMENTAL
Intervention: Brush/Floss (BF)
Number of subjects: 213
Study 35654566 — intervention group
Group type: COMPARATOR
Intervention: Brush only (BO)
Number of subjects: 213
Study 35654566 — intervention group
Group type: COMPARATOR
Intervention: Brush/Rinse (BR)
Number of subjects: 213
Study 33114131 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright Light Therapy (BLT)
Number of subjects: 60
Study 33114131 — intervention group
Group type: COMPARATOR
Intervention: Routine care control group
Number of subjects: 60
Study 35894991 — intervention group
Group type: EXPERIMENTAL
Intervention: Functional Motor Control (FMC) exercises
Number of subjects: 60
Study 35894991 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic Exercises (TE)
Number of subjects: 60
Study 35894991 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 60
Study 33851953 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 17160
Study 33851953 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17160
Study 32912978 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 14
Study 32912978 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 35797703 — intervention group
Group type: EXPERIMENTAL
Intervention: ToM training
Number of subjects: 90
Study 35797703 — intervention group
Group type: COMPARATOR
Intervention: Physical-conversation training
Number of subjects: 90
Study 34556107 — intervention group
Group type: EXPERIMENTAL
Intervention: Chitosan-based varnish (UNO Gel Bioschell, Germiphene corp.) applied weekly for 6 weeks
Number of subjects: 20
Study 34556107 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine-fluoride varnish (Cervitec F, Ivoclar Vivadent) applied weekly for 6 weeks
Number of subjects: 20
Study 34556107 — intervention group
Group type: COMPARATOR
Intervention: Both varnishes
Number of subjects: 20
Study 32215834 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine 200 mg daily for 1 week
Number of subjects: 16
Study 32215834 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 35247108 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-referential stimuli in SART for ADHD group
Number of subjects: 114
Study 35247108 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate for ADHD group
Number of subjects: 114
Study 35247108 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate in classroom study
Number of subjects: 114
Study 35247108 — intervention group
Group type: EXPERIMENTAL
Intervention: Free play mind-wandering condition
Number of subjects: 114
Study 35247108 — intervention group
Group type: COMPARATOR
Intervention: Control condition (newscast)
Number of subjects: 114
Study 36089229 — intervention group
Group type: EXPERIMENTAL
Intervention: GLAD programme (8-week exercise and education programme)
Number of subjects: 206
Study 36089229 — intervention group
Group type: COMPARATOR
Intervention: Open-label placebo (OLP, 4 intra-articular saline injections over 8 weeks)
Number of subjects: 206
Study 34532299 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin, 550 mg twice daily
Number of subjects: 0
Study 34532299 — intervention group
Group type: EXPERIMENTAL
Intervention: C. jejuni infection
Number of subjects: 0
Study 32989073 — intervention group
Group type: EXPERIMENTAL
Intervention: Engaging underserved populations in preventive care through online, personalized, educational material
Number of subjects: 2417
Study 32989073 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of the patient‐clinician relationship
Number of subjects: 2417
Study 32989073 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharing the decision about screening options with the clinician
Number of subjects: 2417
Study 32989073 — intervention group
Group type: EXPERIMENTAL
Intervention: Being given a choice about screening options
Number of subjects: 2417
Study 32989073 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional factors (race, employment, insurance, education)
Number of subjects: 2417
Study 33926838 — intervention group
Group type: EXPERIMENTAL
Intervention: Focal Cryotherapy (FC)
Number of subjects: 121
Study 33926838 — intervention group
Group type: COMPARATOR
Intervention: Active Surveillance (AS)
Number of subjects: 121
Study 34790373 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbon nanoparticles suspension injections (CNS) administered endoscopically within 24 hours prior to neoadjuvant chemotherapy (NCT).
Number of subjects: 160
Study 32678789 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-axis force gauge
Number of subjects: 0
Study 32678789 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-axis force gauge at fast pace
Number of subjects: 0
Study 32678789 — intervention group
Group type: COMPARATOR
Intervention: Current standard measurement methods
Number of subjects: 0
Study 33523572 — intervention group
Group type: EXPERIMENTAL
Intervention: Infant-directed singing
Number of subjects: 2
Study 33523572 — intervention group
Group type: COMPARATOR
Intervention: Infant-directed speech
Number of subjects: 2
Study 36161778 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined intervention of 25° upper body elevation and hand massage
Number of subjects: 46
Study 36161778 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 46
Study 32469621 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 443
Study 32469621 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 443
Study 32422373 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 337
Study 32422373 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 337
Study 34533847 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-sectorial lung team
Number of subjects: 109
Study 34533847 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 109
Study 33591821 — intervention group
Group type: EXPERIMENTAL
Intervention: IMR ≤32 and LVEDP ≤18
Number of subjects: 131
Study 33591821 — intervention group
Group type: EXPERIMENTAL
Intervention: IMR >32 and LVEDP >18
Number of subjects: 131
Study 33591821 — intervention group
Group type: EXPERIMENTAL
Intervention: LVEDP >18
Number of subjects: 131
Study 33591821 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospitalization for heart failure
Number of subjects: 131
Study 33591821 — intervention group
Group type: EXPERIMENTAL
Intervention: Major adverse cardiac events
Number of subjects: 131
Study 35732064 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher Brain Living (HBL) therapy
Number of subjects: 77
Study 35732064 — intervention group
Group type: COMPARATOR
Intervention: Control group (no HBL sessions)
Number of subjects: 77
Study 33407784 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based couple visits
Number of subjects: 1080
Study 33407784 — intervention group
Group type: COMPARATOR
Intervention: HIV self-testing kits for couple use
Number of subjects: 1080
Study 33407784 — intervention group
Group type: COMPARATOR
Intervention: Standard care (male partner clinic invitation letters)
Number of subjects: 1080
Study 36066854 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/d of trans-resveratrol (RSV) for 3 months (90 days)
Number of subjects: 5
Study 36066854 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg/d of trans-resveratrol (RSV)
Number of subjects: 5
Study 32039938 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-assisted laparoscopy (RAL)
Number of subjects: 22
Study 32039938 — intervention group
Group type: COMPARATOR
Intervention: 3-dimensional conventional laparoscopy (3D-CL)
Number of subjects: 22
Study 616631076 — intervention group
Group type: EXPERIMENTAL
Intervention: lienal polypeptide injection combined with chemotherapy
Number of subjects: 60
Study 616631076 — intervention group
Group type: COMPARATOR
Intervention: chemotherapy only
Number of subjects: 60
Study 35695582 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine (mean dosage = 39.56 mg/day)
Number of subjects: 61
Study 35695582 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study 33601937 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous immunoglobulin (IVIG) [Octagam 5%]
Number of subjects: 21
Study 32398120 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized treatment algorithm based on ultrasonographic examination
Number of subjects: 300
Study 32398120 — intervention group
Group type: COMPARATOR
Intervention: Non-operative treatment (Control group A)
Number of subjects: 300
Study 32398120 — intervention group
Group type: COMPARATOR
Intervention: Operative treatment (Control group B)
Number of subjects: 300
Study 33165168 — intervention group
Group type: EXPERIMENTAL
Intervention: PGx‐treatment group (200 mg isoniazid)
Number of subjects: 100
Study 33165168 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard‐treatment group (300 mg isoniazid)
Number of subjects: 100
Study 33165168 — intervention group
Group type: COMPARATOR
Intervention: Reference group (300 mg isoniazid for NAT2 rapid acetylators)
Number of subjects: 100
Study 35314092 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel treatment (specific dosage and duration not mentioned)
Number of subjects: 2282
Study 35314092 — intervention group
Group type: EXPERIMENTAL
Intervention: PSA kinetic metrics (absolute value, best percentage change, tumour growth rate)
Number of subjects: 2282
Study 35314092 — intervention group
Group type: EXPERIMENTAL
Intervention: Best percentage change (BPCH)
Number of subjects: 2282
Study 32145674 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cranial electrotherapy stimulation (CES) - 500μA-2mA for 30 minutes per day for 4 weeks.
Number of subjects: 62
Study 32145674 — intervention group
Group type: COMPARATOR
Intervention: Sham cranial electrotherapy stimulation (CES) - lower than 100μA for 30 minutes per day for 4 weeks.
Number of subjects: 62
Study 32145674 — intervention group
Group type: EXPERIMENTAL
Intervention: Active cranial electrotherapy stimulation (CES)
Number of subjects: 62
Study 35984521 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative bowel stimulation (10 outpatient sessions within 3 weeks prior to ileostomy closure)
Number of subjects: 96
Study 35984521 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative bowel stimulation
Number of subjects: 96
Study 35984521 — intervention group
Group type: COMPARATOR
Intervention: No stimulation (control group)
Number of subjects: 96
Study 33949237 — intervention group
Group type: EXPERIMENTAL
Intervention: Awake prone positioning
Number of subjects: 60
Study 33949237 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 60
Study 34022524 — intervention group
Group type: EXPERIMENTAL
Intervention: Perampanel
Number of subjects: 1374
Study 34022524 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1374
Study 32871556 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 32
Study 32871556 — intervention group
Group type: COMPARATOR
Intervention: Small-Sided Games (SSGs)
Number of subjects: 32
Study 32871556 — intervention group
Group type: COMPARATOR
Intervention: Comparison between HIIT and SSGs
Number of subjects: 32
Study 36266402 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-week residential group program based on mindfulness training, artistic expression, and EMDR group therapy
Number of subjects: 44
Study 35861215 — intervention group
Group type: EXPERIMENTAL
Intervention: Restorative yoga
Number of subjects: 35
Study 35861215 — intervention group
Group type: COMPARATOR
Intervention: Vigorous yoga
Number of subjects: 35
Study 33317981 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.4 km time trial (TT)
Number of subjects: 33
Study 33317981 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2 km, 1.6 km, and 2.0 km time trials (TT)
Number of subjects: 33
Study 33317981 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.2 km to 2.2 km time trials (TT)
Number of subjects: 33